BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

32 related articles for article (PubMed ID: 12109939)

  • 1. Comparison of double-filtration plasmapheresis (DFPP) versus heparin-mediated extracorporeal LDL-precipitation (HELP)-apheresis in early-onset preeclampsia.
    Winkler K; Lorey C; Contini C; Augustinski V; Pütz G; Röthele E; Benner A; Fuchs H; Pecks U; Markfeld-Erol F; Kunze M
    Pregnancy Hypertens; 2024 Jun; 36():101128. PubMed ID: 38728925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in Water Properties in Human Tissue after Double Filtration Plasmapheresis-A Case Study.
    Scholkmann F; Tsenkova R
    Molecules; 2022 Jun; 27(12):. PubMed ID: 35745071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic Plasma Exchange: For Cancer Patients.
    Hu Y; Yang H; Fu S; Wu J
    Cancer Manag Res; 2022; 14():411-425. PubMed ID: 35140519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case Report: Effects of Anti-SARS-CoV-2 Convalescent Antibodies Obtained With Double Filtration Plasmapheresis.
    Curtò D; Tomatis F; Gastoldi S; Galbusera M; Noris M; Raimondi F; Lorini FL; Falanga A; Marchetti M; Remuzzi G; Ruggenenti P
    Front Immunol; 2021; 12():711915. PubMed ID: 34276706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current topics in therapeutic plasmapheresis.
    Nakanishi T; Suzuki N; Kuragano T; Nagasawa Y; Hasuike Y
    Clin Exp Nephrol; 2014 Feb; 18(1):41-9. PubMed ID: 23887747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double filtration plasmapheresis: Review of current clinical applications.
    Hirano R; Namazuda K; Hirata N
    Ther Apher Dial; 2021 Apr; 25(2):145-151. PubMed ID: 32558286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous monitoring of blood volume in double filtration plasmapheresis.
    Mineshima M; Eguchi K; Horibe K; Yokoi R; Kaneko I; Kimata N; Sanaka T; Nihei H; Agishi T
    ASAIO J; 1998; 44(5):M465-9. PubMed ID: 9804474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimum albumin concentration of supplementation fluid for double filtration plasmapheresis.
    Mineshima M; Agishi T; Hasuo Y; Era K; Suzuki T; Teraoka S; Ota K
    Artif Organs; 1992 Oct; 16(5):510-3. PubMed ID: 10078302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of immunoglobulin M reduction via therapeutic dose of simple plasma exchange and double filtration plasmapheresis using membrane separation in patients with hyperviscosity syndrome caused by Waldenstrom macroglobulinemia.
    Miyamoto Y; Hamasaki Y; Matsumoto A; Doi K; Noiri E; Nangaku M
    J Clin Apher; 2018 Oct; 33(5):611-615. PubMed ID: 30188580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma adsorption in critical care.
    Yang KS; Kenpe K; Yamaji K; Tsuda H; Hashimoto H
    Ther Apher; 2002 Jun; 6(3):184-8. PubMed ID: 12109940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double filtration plasmapheresis in critical care.
    Mineshima M; Akiba T
    Ther Apher; 2002 Jun; 6(3):180-3. PubMed ID: 12109939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double filtration plasmapheresis: Determination of the optimal albumin concentration in the supplementation fluid.
    Mineshima M
    Transfus Apher Sci; 2017 Oct; 56(5):654-656. PubMed ID: 28917572
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.